Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antisense RNA targeting PMP22 for the treatment of Charcot-Marie-Tooth 1A disease

Antisense RNA targeting PMP22 for the treatment of Charcot-Marie-Tooth 1A disease

US Patent 11939577 · Granted Mar 26, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Azobenzene derivatives, process for their preparation and their use for therapeu2025
Bioconjugates of neuropeptides derivatives2023
Organic/inorganic hybrid nanoparticulates made from iron carboxylates2020
Porous solid with outer surface grafted with a polymer2019
Antiviral agents directed against respiratory syncytial virus2019
Antiviral agents directed against respiratory syncytial virus2019
Derivatives of oxazaphosphorines that are pre-activated, use and method of prepa2018
Derivatives of oxazaphosphorines that are pre-activated, use and method of prepa2018
Derivatives of oxazaphosphorines and therapeutic uses thereof2018
Derivatives of oxazaphosphorines and therapeutic uses thereof2018
Organic/inorganic hybrid nanoparticulates made from iron carboxylates2018
Derivatives of oxazaphosphorines that are pre-activated, use and method of prepa2016